In a significant move to enhance global preparedness against mpox, Danish biotechnology company Bavarian Nordic has entered a license and manufacturing agreement with the Serum Institute of India (SII). The collaboration aims to increase manufacturing capacity for Bavarian Nordic’s MVA-BN® mpox vaccine and ensure broader, equitable access to vulnerable populations.
Technology Transfer to Expand Production in India
As part of the agreement, Bavarian Nordic will conduct...
India is on the brink of a transformative journey in the global medical technology (MedTech) sector. According to a report by EY India, the country’s MedTech market, which currently holds a 1.6% share in the global industry, is set to grow to 10-12% over the next 25 years. This monumental shift reflects India’s potential to evolve from a significant importer of medical devices to...
The fight against obesity and diabetes in India is set to receive a significant boost with the potential introduction of a production-linked incentive (PLI) scheme. The scheme, aimed at enhancing the production of drugs for these conditions, is expected to be rolled out in 2026. This move could revolutionize the availability and development of critical medications in the country, particularly GLP-1 (glucagon-like peptide-1) receptor...
Serum Institute of India Pvt., the world's largest vaccine maker, is expanding its production capacity. The company expects sales of life-saving vaccines, including those for malaria and cervical cancer, to double in the next five years.
Increasing Production Capacity
Serum Institute currently has the capacity to produce 3 billion doses of various vaccines annually. However, it only sells about 1.5 billion doses each year. The Pune-based...
Infosys has announced a significant collaboration with Nihon Chouzai (TSE), Japan’s leading dispensing pharmacy chain, to expand healthcare access in Japan through enhanced online medication guidance services and payment solutions. This partnership aims to revolutionize how patients in Japan receive medical guidance, leveraging digital innovation to eliminate the need for physical pharmacy visits and enhance overall healthcare efficiency.
Development and Launch of NiCOMS Mobile Application
As...
Biocon Limited recently announced an exclusive licensing and supply agreement with Handok, a leading specialty pharmaceutical company in South Korea. This collaboration focuses on the commercialization of Biocon’s innovative drug product, Synthetic Liraglutide. The drug is used for chronic weight management and comes in the form of an injection in a pre-filled pen.
Strategic Partnership and Objectives
Under the agreement, Biocon will handle the development, manufacturing,...
Cipla Limited has declared a fresh investment of Rs. 26 crore in Achira Labs Private Limited. This financial input, distributed across four tranches, depends on the achievement of certain developmental milestones. Through this move, Cipla underscores its commitment to advancing its role in the point-of-care (PoC) diagnostics space—a crucial element of modern healthcare.
Cipla's Global Influence in Pharmaceuticals
Cipla Limited is a leading global pharmaceutical company,...
In today's digitally driven world, India's healthcare sector is undergoing a profound transformation, leveraging technology to enhance patient care and streamline operations. However, alongside these advancements comes an increased risk of cyber threats. With the adoption of electronic health records (EHRs), telemedicine, and other digital health services on the rise, it becomes imperative for Indian organizations to prioritize healthcare cybersecurity.
This article delves into...
The healthcare innovation landscape in India is poised for significant growth, with projections indicating a doubling of market value by FY28. A recent report by Bain & Company and HealthQuad sheds light on the promising trajectory of healthcare innovation. It forecasts a rise from the current $30 billion to an impressive $60 billion by 2028.
Rapid Expansion Amidst Market Growth
India's healthcare innovation sector currently accounts...
Healthcare disparities persist as a significant challenge worldwide, with marginalized communities often facing barriers to accessing quality healthcare services. Addressing healthcare disparities is crucial for promoting health equity and ensuring that all individuals have equal opportunities to lead healthy lives. In this blog, we will explore the strategies for improving access and equity in healthcare, along with relevant statistics to highlight the scope of...
In a significant move to enhance global preparedness against mpox, Danish biotechnology company Bavarian Nordic has entered a license and manufacturing agreement with the Serum Institute of India (SII). The collaboration aims to increase manufacturing capacity for Bavarian Nordic’s MVA-BN® mpox vaccine and ensure broader, equitable access to vulnerable populations.
Technology Transfer to Expand Production in India
As part of the agreement, Bavarian Nordic will conduct...